Do Analysts Expect Adagio Therapeutics Inc (ADGI) Stock to Rise After It Is Up 34.95% in a Month?

Friday, July 22, 2022 02:16 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Expect Adagio Therapeutics Inc (ADGI) Stock to Rise After It Is Up 34.95% in a Month?

Analysts who follow Adagio Therapeutics Inc (ADGI) on average expect it to fall -8.08% over the next twelve months. Those same analysts give the stock an average rating of Hold. That average rating earns Adagio Therapeutics Inc an Analyst Ranking of 3, which means it ranks higher than 3 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating ADGI a Hold today. Find out what this means to you and get the rest of the rankings on ADGI!

See Full ADGI Report

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Adagio Therapeutics Inc Stock Today?

Adagio Therapeutics Inc (ADGI) stock is trading at $4.17 as of 2:11 PM on Friday, Jul 22, a decline of -$0.23, or -5.23% from the previous closing price of $4.40. The stock has traded between $4.17 and $4.40 so far today. Volume today is low. So far 144,174 shares have traded compared to average volume of 854,721 shares. Click Here to get the full Stock Report for Adagio Therapeutics Inc stock.